Inhibition of USP4 attenuates pathological scarring by downregulation of the TGF‑β/Smad signaling pathway

Zhang,Jie; Na,Sijia; Pan,Shuting; Long,Sang; Xin,Yuqi; Jiang,Qingkun; Lai,Zhongwei; Yan,Junfeng; Cao,Zhongyi

doi:10.3892/mmr.2019.10370

Inhibition of USP4 attenuates pathological scarring by downregulation of the TGF‑β/Smad signaling pathway

Authors:
- Jie Zhang
- Sijia Na
- Shuting Pan
- Sang Long
- Yuqi Xin
- Qingkun Jiang
- Zhongwei Lai
- Junfeng Yan
- Zhongyi Cao
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: June 6, 2019 https://doi.org/10.3892/mmr.2019.10370
Pages: 1429-1435

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pathological scarring is a result of the hypertrophy of scar tissue during tissue repair following trauma. The aim of the present study was to assess the effect of ubiquitin‑specific protease 4 (USP4) silencing on pathological scarring, and to evaluate the mechanistic basis for the effect. An MTT assay was used to assess cell viability. Immunoprecipitation (IP) was used to determine ubiquitination levels of the TGF‑β receptor (TβR)I and Smad7. Tumor formation was assessed by injecting keloid fibroblasts. Hematoxylin and eosin staining was used to detect pathological changes in tumor tissue. Reverse transcription quantitative polymerase chain reaction and western blot analysis assays were used to evaluate the expression levels of TβRI and Smad7. Compared with the untreated control animals, cell viability and the expression of TβRI and Smad7 increased significantly in animals treated with TGF‑β. Short hairpin RNA for USP4 (shUSP4) decreased the cell viability of negative control cells, TGF‑β‑induced cellular proliferation, and the expression of TβRI and Smad7. IP experiments indicated that the ubiquitination level of TβRI was decreased following USP4 silencing. There was no remarkable difference in the structure of scar tissue among the various animal groups at 14 days following treatment, while the necrotic area of the scar tissue in the shUSP4 and vialinin A (USP inhibitor)‑treated animals increased significantly at the 28th and 42nd day compared with the control animals. At days 14, 28 and 42, the expression levels of TβRI and Smad7 in the shUSP4 and vialinin A‑treated animals were significantly decreased compared with the control animals (P<0.05). In summary, interference with or inhibition of USP4 prevented the activity of the TGF‑β/Smad pathway signaling and inhibited the formation of pathological scars.

View Figures

View References

1	Song H, Tan J, Fu Q, Huang L and Ao M: Comparative efficacy of intralesional triamcinolone acetonide injection during early and static stage of pathological scarring. J Cosmet Dermatol. Jun 22–2018.(Epub ahead of print).
2	Liao N, Lu F, Zhao W, Zeng WS, Li YT, Wang SJ and Gao JH: Relationship between gene p53 codon 72 polymorphism and pathological scar formation after caesarean section. Zhonghua Zheng Xing Wai Ke Za Zhi. 29:206–210. 2013.(In Chinese). PubMed/NCBI
3	Wu WY, Zhang LT, Zheng ZF, Zhu SZ and Wang ZY: Expression and significance of mRNA and protein of eIF4E, p-eIF4E and MCl-1 in pathological scar. Zhonghua Zheng Xing Wai Ke Za Zhi. 28:360–365. 2012.(In Chinese). PubMed/NCBI
4	DeSalle LM, Latres E, Lin D, Graner E, Montagnoli A, Baker RT, Pagano M and Loda M: The de-ubiquitinating enzyme Unp interacts with the retinoblastoma protein. Oncogene. 20:5538–5542. 2001. View Article : Google Scholar : PubMed/NCBI
5	Wada K and Kamitani T: UnpEL/Usp4 is ubiquitinated by Ro52 and deubiquitinated by itself. Biochem Biophys Res Commun. 342:253–258. 2006. View Article : Google Scholar : PubMed/NCBI
6	Yan X, Liao H, Cheng M, Shi X, Lin X, Feng XH and Chen YG: Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling. J Biol Chem. 291:382–392. 2016. View Article : Google Scholar : PubMed/NCBI
7	Dong X, Zhao B, Iacob RE, Zhu J, Koksal AC, Lu C, Engen JR and Springer TA: Force interacts with macromolecular structure in activation of TGF-β. Nature. 542:55–59. 2017. View Article : Google Scholar : PubMed/NCBI
8	Sun Q, Guo S, Wang CC, Sun X, Wang D, Xu N, Jin SF and Li KZ: Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation. Int J Clin Exp Pathol. 8:7631–7639. 2015.PubMed/NCBI
9	Beanes SR, Dang C, Soo C and Ting K: Skin repair and scar formation: The central role of TGF-beta. Exp Rev Mol Med. 5:1–22. 2003. View Article : Google Scholar
10	Penn JW, Grobbelaar AO and Rolfe KJ: The role of the TGF-β family in wound healing, burns and scarring: A review. Int J Burns Trauma. 2:18–28. 2012.PubMed/NCBI
11	Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu CX and ten Dijke P: USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol. 14:717–726. 2012. View Article : Google Scholar : PubMed/NCBI
12	Li W, Tao S, Wu Q, Wu T, Tao R and Fan J: Glutamine reduces myocardial cell apoptosis in a rat model of sepsis by promoting expression of heat shock protein 90. J Surg Res. 220:247–254. 2017. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
14	Zhu G, Li J, He L, Wang X and Hong X: MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway. Br J Pharmacol. 172:2354–2368. 2015. View Article : Google Scholar : PubMed/NCBI
15	Song Z, Chen H, Xu W, Wu S and Zhu G: Basolateral amygdala calpain is required for extinction of contextual fear-memory. Neurobiol Learn Mem. 155:180–188. 2018. View Article : Google Scholar : PubMed/NCBI
16	Xiong G, Huang Z, Jiang H, Pan Z, Xie J and Wang S: Inhibition of microRNA-21 decreases the invasiveness of fibroblast-like synoviocytes in rheumatoid arthritis via TGFβ/Smads signaling pathway. Iran J Basic Med Sci. 19:787–793. 2016.PubMed/NCBI
17	Xu X, Xu C, Saud SM, Lu X, Liu L, Fang L, Zhang X, Hu J and Li W: Effect of kuijie granule on the expression of TGF-β/Smads signaling pathway in patients with ulcerative colitis. Evid Based Complement Alternat Med. 2016:26018302016. View Article : Google Scholar : PubMed/NCBI
18	Zhao B, Schlesiger C, Masucci MG and Lindsten K: The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway. J Cell Mol Med. 13:1886–1895. 2009. View Article : Google Scholar : PubMed/NCBI
19	Milojevic T, Reiterer V, Stefan E, Korkhov VM, Dorostkar MM, Ducza E, Ogris E, Boehm S, Freissmuth M and Nanoff C: The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol. 69:1083–1094. 2006. View Article : Google Scholar : PubMed/NCBI
20	Wijnhoven P, Konietzny R, Blackford AN, Travers J, Kessler BM, Nishi R and Jackson SP: USP4 auto-deubiquitylation promotes homologous recombination. Mol Cell. 60:362–373. 2015. View Article : Google Scholar : PubMed/NCBI
21	Zhang X, Berger FG, Yang J and Lu X: USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. EMBO J. 30:2177–2189. 2011. View Article : Google Scholar : PubMed/NCBI
22	Fan YH, Yu Y, Mao RF, Tan XJ, Xu GF, Zhang H, Lu XB, Fu SB and Yang J: USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. Cell Death Differ. 18:1547–1560. 2011. View Article : Google Scholar : PubMed/NCBI
23	Wang Y, Zhang L, Lei R, Shen Y, Shen H, Wu Z and Xu J: Effects of blocking two sites of transforming growth factor-β/Smads signaling on the formation of scar-related proteins in human skin fibroblasts. Zhonghua Shao Shang Za Zhi. 31:372–377. 2015.(In Chinese). PubMed/NCBI
24	Nong Q, Li S, Wu Y and Liu D: LncRNA COL1A2-AS1 inhibits the scar fibroblasts proliferation via regulating miR-21/Smad7 pathway. Biochem Biophys Res Commun. 495:319–324. 2018. View Article : Google Scholar : PubMed/NCBI
25	Xia W, Phan TT, Lim IJ, Longaker MT and Yang GP: Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen. 12:546–556. 2004. View Article : Google Scholar : PubMed/NCBI
26	Emami A, Halim AS, Salahshourifar I, Yussof SJ, Khoo TL and Kannan TP: Association of TGFβ1 and SMAD4 variants in the etiology of keloid scar in the Malay population. Arch Dermatol Res. 304:541–547. 2012. View Article : Google Scholar : PubMed/NCBI
27	Ward SV, Cadby G, Heyworth JS, Fear MW, Wallace HJ, Cole JM, Wood FM and Palmer LJ: Association of TGFβ1 and clinical factors with scar outcome following melanoma excision. Arch Dermatol Res. 304:343–351. 2012. View Article : Google Scholar : PubMed/NCBI
28	Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, Hsu M and Longaker MT: Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg. 108:423–429. 2001. View Article : Google Scholar : PubMed/NCBI
29	Bock O, Yu H, Zitron S, Bayat A, Ferguson MW and Mrowietz U: Studies of transforming growth factors beta 1–3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol. 85:216–220. 2005.PubMed/NCBI
30	Goldberg HJ, Huszár T, Mózes MM, Rosivall L and Mucsi I: Overexpression of the type II transforming growth factor-beta receptor inhibits fibroblasts proliferation and activates extracellular signal regulated kinase and c-Jun N-terminal kinase. Cell Biol Int. 26:165–174. 2002. View Article : Google Scholar : PubMed/NCBI
31	Bran GM, Goessler UR, Schardt C, Hormann K, Riedel F and Sadick H: Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars. Int J Mol Med. 25:915–921. 2010. View Article : Google Scholar : PubMed/NCBI
32	Li SC, Ma LN, Chen J and Li YK: Effect of allicin on myocardial fibrosis after myocardial infarction in rats and its relationship with TGFβ/Smads signal transduction. Zhongguo Zhong Yao Za Zhi. 41:2517–2521. 2016.(In Chinese). PubMed/NCBI
33	Hu ZC, Shi F, Liu P, Zhang J, Guo D, Cao XL, Chen CF, Qu SQ, Zhu JY and Tang B: TIEG1 Represses Smad7-mediated activation of TGF-β1/Smad signaling in keloid pathogenesis. J Invest Dermatol. 137:1051–1059. 2017. View Article : Google Scholar : PubMed/NCBI
34	D'Arpino MC, Fuchs AG, Sánchez SS and Honoré SM: Extracellular matrix remodeling and TGF-β1/Smad signaling in diabetic colon mucosa. Cell Biol Int. 42:443–456. 2018. View Article : Google Scholar : PubMed/NCBI
35	Popovic D, Vucic D and Dikic I: Ubiquitination in disease pathogenesis and treatment. Nat Med. 20:1242–1253. 2014. View Article : Google Scholar : PubMed/NCBI
36	Wu Y, Kang J, Zhang L, Liang Z, Tang X, Yan Y, Qian H, Zhang X, Xu W and Mao F: Ubiquitination regulation of inflammatory responses through NF-κB pathway. Am J Transl Res. 10:881–891. 2018.PubMed/NCBI
37	Cheng YF, Zhu GQ, Wang M, Cheng H, Zhou A, Wang N, Fang N, Wang XC, Xiao XQ, Chen ZW and Li QL: Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis. Neurosci Res. 63:52–58. 2009. View Article : Google Scholar : PubMed/NCBI